丹参注射液在动脉粥样硬化性脑梗死恢复期中的应用

Application of the Danshen injection in treating atherosclerotic cerebral infarction during recovery period

目的:探讨丹参注射液在动脉粥样硬化性脑梗死恢复期中的作用。方法:选取2015年1月-2017年12月我院收治的94例动脉粥样硬化性脑梗死恢复期患者作为研究对象,按随机数表法分为观察组和对照组,每组47例。对照组给予甘露醇注射液治疗,观察组在此基础上给予丹参注射液治疗。观察两组基线期及治疗后NIHSS积分、MRS积分和BI指数变化,评价两组临床疗效。结果:观察组临床疗效总有效率显著高于对照组,差异具有统计学意义(P <0.05)。基线期,两组NIHSS积分、MRS积分及BI指数比较,差异无统计学意义(P> 0.05);治疗后,观察组NIHSS积分、MRS积分显著低于对照组,差异具有统计学意义(P <0.05);观察组BI指数显著高于对照组,差异具有统计学意义(P <0.05)。结论:丹参注射液在动脉粥样硬化性脑梗死恢复期中的应用,能有效改善患者神经功能和日常生活活动能力。

Objective:To investigate clinical efficacy of the Danshen injection(丹参注射液)on atherosclerotic cerebral infarction recovery period.Methods:From January 2015 to December 2017,94 cases were divided into two groups,47 cases in each.The control group was given mannitol injection;and the observation group was given the Danshen injection more.Results:The total efficiency was higher in the observation group,P<0.05.After treatment,the NIHSS scores and MRS scores in the observation group were significantly lower(P<0.05);the BI index in the observation group was significantly higher(P<0.05).Conclusion:The Danshen injection on atherosclerotic cerebral infarction recovery period shows a good effect,can effectively improve the neurological function and activities of daily living.